Working closely with Cooke is Andrew Bresnahan who is the new vice president of Oncology Services and Cell/Gene Therapy.
“We are thrilled to welcome Andrew to UC Davis Health as we continue to advance patient-centered, comprehensive cancer care and innovative therapies for our community,” said Cooke. “His unique expertise in oncology and cell and gene therapy will help us expand access, improve operational efficiencies, and enhance the experiences of our patients, providers and staff.”
Bresnahan brings more than 15 years of progressive leadership experience, including most recently as the director of oncology at Northwestern Memorial Hospital in Chicago. There, he led operations for the inpatient and outpatient cell therapy departments, oncology services, apheresis center, and cell lab. He played a pivotal role in establishing CAR T-cell and TIL therapies. He also managed non-malignant programs, advancing cell and gene therapy initiatives, and ensuring compliance with industry regulatory and accreditation standards.
